在儿童COVID-19患者持续感染期间,SARS-CoV-2的宿主内部进化
Charlie R Boyle1,2, Tien Doan2,3, Estefany Rios-Guzman2,3
1Division of Pediatric Infectious Diseases, Anne and Robert H. Lurie Children's Hospital, Chicago, IL 60611, USA.
Viruses
|October 29, 2025
概括
患有COVID-19的儿童在成年人持续感染期间表现出类似的SARS-CoV-2演变. 这表明儿科病例有助于病毒多样化和新变种的出现.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 冠状病毒疾病2019 (COVID-19) 在儿童和成年人之间呈现的不同,往往症状较轻.
- 持续的严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染可能导致病毒进化和免疫逃脱,特别是在成人中.
- 在儿童持续感染期间,SARS-CoV-2的进化动态仍然不太清楚.
研究的目的:
- 为了研究小儿COVID-19患者中SARS-CoV-2的宿主内进化.
- 为了比较免疫能力强与免疫性低下儿童的病毒进化.
- 确定儿童是否有助于病毒多样化和新变种的出现.
主要方法:
- 来自儿科患者的纵向SARS-CoV-2标本的全基因组测序.
- 病毒突变和宿主内部多样性的分析.
- 免疫能力强和免疫缺陷儿童之间的进化趋势的比较.
主要成果:
- 在儿科患者中,随着时间的推移,在宿主体内出现了赋予病毒适应性和免疫逃脱的突变.
- 宿主内部的多样性在免疫能力和免疫缺陷儿童中以可比的速度积累.
- 免疫受损的儿童由于感染持续时间较长而具有更多的整体突变.
结论:
- 在儿童持续感染期间,SARS-CoV-2表现出与成人观察到的类似的进化趋势.
- 儿童的持续性感染是病毒多样化的潜在来源.
- 了解儿科病毒演变对于管理COVID-19和预测未来变种至关重要.
相关概念视频
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Stages of Infection
64.8K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
64.8K
Cystic Fibrosis: Pathogenesis
703
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
703
Viral Mutations
39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Infection
11.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion
207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207


